The ground-breaking AI solution operates within AtlantiCare's Lung Nodule Clinic. AtlantiCare was one of the first healthcare organizations in the nation to offer the Ethicon's MONARCH™ robotic bronchoscopy platform, acquired by Johnson & Johnson (NYSE: JNJ) in 2019.
The Virtual Nodule Clinic pre-operative AI assessment helps inform clinical decisions for appropriate follow-up interventions using the MONARCH™ robotic bronchoscopy techniques, with the goal of achieving the earliest possible and least invasive treatment. Thanks to this unique combination, the clinician can find patients with the smallest and hardest to reach tumors and deploy the robotic bronchoscope to reach and biopsy the regions highlighted with the help of the Optellum AI.
Ad Statistics
Times Displayed: 22487
Times Visited: 455 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
"We have already identified suspicious tumors in individuals who have no known risk of lung cancer through this technology," added Borah. "It will enhance the life-saving progress we've experienced since offering robotic bronchoscopy to our patients."
Václav Potěšil PhD, Optellum's founder and chief business officer, also commented on the partnership: "Our collaboration with AtlantiCare is noteworthy because we added a new healthcare system to our growing network, where we can work closely with the interventional pulmonology team to evaluate how combining the powers of the Optellum AI and robotic bronchoscopy platforms impacts health outcomes for patients, and take AI-driven early lung cancer interception to the next level."
About AtlantiCare
AtlantiCare is an integrated healthcare system based in Egg Harbor Township, New Jersey, whose more than 6,000 staff, providers and volunteers serve the community in more than 100 locations in Atlantic, Burlington, Camden, Cape May, and Ocean counties of southern New Jersey. Its vision of building healthy communities together drives its mission of making a difference in health and healing, one person at a time, through caring and trusting relationships. A Malcolm Baldrige National Quality Award winner, AtlantiCare was also included in Modern Healthcare's Best Places to Work. AtlantiCare Regional Medical Center was the 105th hospital in the nation to attain the American Nurses Credentialing Center's Magnet™ designation in 2004 and earned redesignation in 2008, 2013, and 2018.
About Optellum
Optellum is a commercial-stage lung-health company providing artificial intelligence decision-support software that assists physicians in early diagnosis and optimal treatment for their patients. The company was founded so that every lung disease patient is diagnosed and treated at the earliest possible stage, when the probability of better health outcomes is highest. In 2021, the Oxford-based medtech company achieved FDA 510(k) clearance for the application of AI decision-support software in lung cancer diagnosis, and has since announced strategic partnerships in the USA with GE Healthcare and the Lung Cancer Initiative at Johnson & Johnson, while the Virtual Nodule Clinic has been implemented in leading healthcare systems across the USA. Optellum has headquarters at the Oxford Centre for Innovation in Oxford, United Kingdom and a U.S. office at the Texas Medical Center in Houston, Texas.
SOURCE Optellum
Back to HCB News
